Rui Liu
Singleron Biotechnologies (china)(CN)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Epigenetics and DNA Methylation, Pancreatic and Hepatic Oncology Research, Genetic factors in colorectal cancer, Radiomics and Machine Learning in Medical Imaging
Most-Cited Works
- → Non-invasive early detection of cancer four years before conventional diagnosis using a blood test(2020)628 cited
- → Ultrasensitive and affordable assay for early detection of primary liver cancer using plasma cell‐free DNA fragmentomics(2021)108 cited
- → Early Detection of Molecular Residual Disease and Risk Stratification for Stage I to III Colorectal Cancer via Circulating Tumor DNA Methylation(2023)106 cited
- → Multidimensional Cell-Free DNA Fragmentomic Assay for Detection of Early-Stage Lung Cancer(2022)88 cited
- → Letter to the Editor: An ultra-sensitive assay using cell-free DNA fragmentomics for multi-cancer early detection(2022)84 cited
- → Multi-dimensional fragmentomic assay for ultrasensitive early detection of colorectal advanced adenoma and adenocarcinoma(2021)74 cited
- → Sensitive detection of stage I lung adenocarcinoma using plasma cell-free DNA breakpoint motif profiling(2022)70 cited
- → Circulating cell-free DNA-based multi-cancer early detection(2023)60 cited
- → Homologous recombination deficiency in diverse cancer types and its correlation with platinum chemotherapy efficiency in ovarian cancer(2022)54 cited
- → Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA(2022)44 cited